Organogenesis: Q1 Earnings Snapshot
In this article:
CANTON, Mass. (AP) — CANTON, Mass. (AP) — Organogenesis Holdings Inc. (ORGO) on Wednesday reported a loss of $3 million in its first quarter.
On a per-share basis, the Canton, Massachusetts-based company said it had a loss of 2 cents.
The regenerative medicine company posted revenue of $107.6 million in the period.
Organogenesis expects full-year revenue in the range of $454 million to $466 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ORGO at https://www.zacks.com/ap/ORGO
